Technical charts show 50-day moving average aligning with key support at $32.20. Meanwhile, the company is in the midst of a buyback program. It plans to repurchase 700 million pounds ($899.7 million) worth of shares this year and 900 million pounds ($1.2 billion) next year. The company is using proceeds from a partial sale it made in Indian tobacco company, ITC, to fund the repurchase plan. The company sold its stake in March, but it still owns over 25% of ITC. Its remaining ITC stake is also another asset to consider when looking at the stock. Valuation-wise, BTI appears attractively priced, trading at just 10.4x projected 2025 earnings—slightly below Altria’s multiple and roughly half the valuation of the broader market. In addition to its dividend, BTI is actively returning capital to shareholders through stock buybacks . Following the partial sale of its stake in Indian conglomerate ITC, the company raised its 2025 buyback program to £1.1 billion. Analysts tracking the BTI stock price forecast note moderate upward momentum, with RSI levels near 55 indicating room for growth. British American Tobacco’s cost-cutting measures and next-gen product expansion continue supporting its valuation.